Karpman Craig, Benzo Roberto
Mindful Breathing Laboratory, Mayo Clinic, Division of Pulmonary and Critical Care Medicine, Rochester, MN, USA.
Int J Chron Obstruct Pulmon Dis. 2014 Nov 21;9:1315-20. doi: 10.2147/COPD.S54481. eCollection 2014.
Chronic obstructive pulmonary disease (COPD) is a disease associated with dyspnea, fatigue, and exercise intolerance. The degree of functional debility and level of exercise capacity greatly influences quality of life and mortality in patients with COPD, and the measures of exercise capacity are to be an integral part of patient assessment but often not feasible in routine daily practice, resulting in likely suboptimal care. There is a need for simple ways to identify functional decline in the clinical setting in order to guide resources to preventive interventions or proper care, including palliative care. Gait speed, or measuring how long it takes for a patient to walk a short distance, takes very little time and space, and can serve as a candidate measure of physical function in COPD. Gait speed has been shown to be an indicator of disability, health care utilization, and survival in older adults. It is a simple, reliable, and feasible measure to perform in the clinic and has been promoted as the next vital sign, providing insight into patients' functional capacity. Gait speed is mainly determined by exercise capacity but reflects global well-being as it captures many of the multisystemic effects of disease severity in COPD rather than pulmonary impairment alone. It is an excellent screening measure for exercise capacity and frailty; in COPD, the usual gait speed (4-m course with rolling start) has been very accurate in identifying clinically relevant benchmarks of the 6-minute walk test, poor (<350 m) and very poor (<200 m) 6-minute walk test distances. A specific cut-off point of 0.8 m · s(-1) had a positive predictive value of 69% and negative predictive value of 98% in predicting very poor exercise capacity. The increasing evidence on gait speed is promising as a simple test that can inform the clinician about many important functional aspects of the COPD patient. Further work will likely show the strength of gait speed as a predictive marker of hospitalizations, re-admissions, and mortality. Instead of relying on the "eyeball test" regarding the patient's frailty or exercise capacity, a gait speed in its simplicity represents a much more solid assessment. Furthermore, repeat measures over serial clinic visits may show a pattern and further guide a change in therapy, whether it be medications, rehabilitation, or even initiation of palliative care discussions.
慢性阻塞性肺疾病(COPD)是一种与呼吸困难、疲劳和运动不耐受相关的疾病。功能衰弱程度和运动能力水平对COPD患者的生活质量和死亡率有很大影响,运动能力的测量应是患者评估的一个组成部分,但在日常实践中往往不可行,这可能导致护理效果欠佳。需要有简单的方法在临床环境中识别功能下降,以便将资源导向预防性干预措施或适当的护理,包括姑息治疗。步速,即测量患者走一小段距离所需的时间,所需时间和空间很少,可以作为COPD患者身体功能的一个候选测量指标。步速已被证明是老年人残疾、医疗保健利用和生存的一个指标。它是一种在诊所进行的简单、可靠且可行的测量方法,并已被推广为下一个生命体征,可深入了解患者的功能能力。步速主要由运动能力决定,但反映了整体健康状况,因为它捕捉了COPD疾病严重程度的许多多系统影响,而不仅仅是肺部损害。它是运动能力和虚弱的一种优秀筛查指标;在COPD中,通常的步速(滚动起跑4米路程)在识别6分钟步行试验的临床相关基准方面非常准确,即6分钟步行试验距离差(<350米)和非常差(<200米)。在预测运动能力非常差时,0.8米·秒⁻¹的特定截断点的阳性预测值为69%,阴性预测值为98%。关于步速的越来越多的证据表明,它作为一种简单的测试很有前景,可为临床医生提供有关COPD患者许多重要功能方面的信息。进一步的研究可能会显示步速作为住院、再次入院和死亡率预测指标的优势。与其依赖关于患者虚弱或运动能力的“直观判断”,简单的步速代表了一种更可靠的评估。此外,在连续的门诊就诊中重复测量可能会显示出一种模式,并进一步指导治疗的改变,无论是药物治疗、康复治疗,甚至是开始姑息治疗讨论。